DKS Co., Ltd. (JP:4461)
:4461
Want to see JP:4461 full AI Analyst Report?
Top Page
DKS Co., Ltd.
(4461)
Select Model
Select Model
Rating:74Outperform
Price Target:
¥10,562.00
▲(28.34% Upside)
Action:Upgraded
Date:05/15/26
The score is driven primarily by improving financial performance (strong 2026 recovery in growth, margins, and leverage) and supportive technical momentum (price above key moving averages with positive MACD). Valuation is reasonable (P/E ~12.2) with a modest dividend yield, while historical earnings and cash-flow volatility temper the overall rating.
Positive Factors
Diversified industrial end-markets
DKS sells functional chemicals, resins and surface agents into electronics, automotive and pharmaceutical industries. This multi-industry exposure supports more durable demand, cross-selling and product specialization, lowering reliance on any single sector over a 2–6 month horizon.
Negative Factors
Earnings cyclicality and volatility
Historic swings from a loss to recovery show the business is cyclically sensitive. Such volatility hinders forecasting, makes capital allocation and dividend consistency harder, and raises probability that margins and returns can revert when end-market demand softens.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified industrial end-markets
DKS sells functional chemicals, resins and surface agents into electronics, automotive and pharmaceutical industries. This multi-industry exposure supports more durable demand, cross-selling and product specialization, lowering reliance on any single sector over a 2–6 month horizon.
Read all positive factors
DKS Co., Ltd. (4461) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥89.84B
Dividend Yield1.24%
Average Volume (3M)144.71K
Price to Earnings (P/E)12.2
Beta (1Y)1.51
Revenue Growth13.15%
EPS Growth122.76%
CountryJP
Employees1,111
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)309.33
Shares Outstanding10,684,321
10 Day Avg. Volume174,660
30 Day Avg. Volume144,713
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.45
Price to Sales (P/S)0.91
P/FCF Ratio11.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)612.6
Revenue Forecast (FY)¥87.00B
DKS Co., Ltd. Business Overview & Revenue Model
Company Description
DKS Co. Ltd. produces and sells surfactants and other industrial chemicals for various industries in Japan and internationally. It operates through six segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electro...
How the Company Makes Money
DKS Co., Ltd. generates revenue through the production and sale of its chemical products to industrial clients across multiple sectors. Its key revenue streams include functional chemicals for electronics and automotive applications, as well as sy...
DKS Co., Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
70
Positive
Cash Flow
67
Positive
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.77B | 82.89B | 73.25B | 63.12B | 65.08B | 62.67B |
| Gross Profit | 19.24B | 24.79B | 18.24B | 13.15B | 12.96B | 15.72B |
| EBITDA | 9.10B | 13.33B | 8.68B | 5.85B | 3.83B | 7.98B |
| Net Income | 2.96B | 6.17B | 2.58B | 1.17B | -407.00M | 2.49B |
Balance Sheet | ||||||
| Total Assets | 94.19B | 115.00B | 97.11B | 94.54B | 85.03B | 86.47B |
| Cash, Cash Equivalents and Short-Term Investments | 15.44B | 24.03B | 16.75B | 16.13B | 9.13B | 12.22B |
| Total Debt | 29.98B | 29.14B | 31.35B | 35.14B | 32.47B | 30.87B |
| Total Liabilities | 50.29B | 56.74B | 52.60B | 53.24B | 46.73B | 46.08B |
| Stockholders Equity | 38.95B | 52.04B | 38.73B | 36.75B | 34.35B | 36.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.34B | 5.39B | 4.59B | -2.11B | 2.86B |
| Operating Cash Flow | 0.00 | 9.96B | 7.53B | 7.09B | 724.00M | 5.52B |
| Investing Cash Flow | 0.00 | -3.54B | -2.14B | -2.01B | -2.88B | -2.70B |
| Financing Cash Flow | 0.00 | 854.00M | -5.04B | 1.65B | -1.03B | -2.34B |
DKS Co., Ltd. Technical Analysis
Negative
8230.00
Price Trends
8645.95
Negative
9172.64
Negative
7670.43
Positive
Market Momentum
125.47
Negative
46.45
Neutral
16.25
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4461, the sentiment is Negative. The current price of 8230 is below the 20-day moving average (MA) of 8648.50, below the 50-day MA of 8645.95, and above the 200-day MA of 7670.43, indicating a neutral trend. The MACD of 125.47 indicates Negative momentum. The RSI at 46.45 is Neutral, neither overbought nor oversold. The STOCH value of 16.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4461.
DKS Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥178.75B | 18.85 | ― | 0.93% | 23.76% | 212.38% | |
79 Outperform | ¥110.96B | 7.03 | 9.19% | 3.33% | -10.12% | 276.36% | |
76 Outperform | ¥105.78B | 17.95 | ― | 1.30% | 26.33% | 11.15% | |
74 Outperform | ¥89.84B | 12.24 | ― | 1.24% | 13.15% | 122.76% | |
70 Outperform | ¥126.18B | 10.95 | 5.56% | 2.59% | 1.68% | 0.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥112.27B | 12.13 | ― | 3.77% | -1.80% | -28.55% |
* Basic Materials Sector Average
JP:4461
DKS Co., Ltd.
8,490.00
5,387.81
173.68%
JP:4958
T Hasegawa Co
3,070.00
323.52
11.78%
JP:4471
Sanyo Chemical Industries
5,030.00
1,483.12
41.81%
JP:4369
Tri Chemical Laboratories Inc.
3,255.00
493.03
17.85%
JP:4914
Takasago International Corporation
1,120.00
-100.79
-8.26%
JP:4971
MEC Company Ltd.
9,660.00
7,291.56
307.86%
DKS Co., Ltd. Corporate Events
DKS Weighs Investment Unit Cut to Broaden Investor Base
May 13, 2026
DKS Co., Ltd. has announced that its board of directors has adopted an approach and policy for potentially reducing the investment unit of its shares, aiming to make the stock more attractive by broadening its investor base and improving liquidity...
DKS Co. Delivers Strong Earnings and Hikes Dividend as Financial Base Strengthens
May 13, 2026
DKS Co., Ltd. reported strong consolidated results for the year ended March 31, 2026, with net sales rising 13.1% to ¥82.9 billion and operating income surging 88.9% to ¥10.1 billion, while profit attributable to owners of parent more th...
DKS to Book ¥1.9 Billion in Subsidiary Dividends With No Consolidated Impact
Apr 9, 2026
DKS Co., Ltd. announced that it will receive dividends totaling ¥1,924 million from four consolidated subsidiaries, with receipt scheduled between March 31, 2026, and May 25, 2026. The dividend income will be recorded as non-operating income ...
DKS Elevates Representative Director to Bolster SMART 2030 Execution
Feb 24, 2026
DKS Co., Ltd. announced that its Board of Directors has approved a change in the title of Representative Director SHIMIZU Shinji, effective April 1, 2026, promoting him from Representative Managing Director CFO to Representative Senior Managing D...
DKS Co. Nominates Academic as New Outside Director to Bolster Governance
Feb 24, 2026
DKS Co., Ltd. has nominated academic Shigeki Sakurai, Professor Emeritus at Kyoto University and Kaishi Professional University, as a candidate for Outside Director, following a resolution by its Board of Directors on February 24, 2026. The appoin...
DKS Reshapes Organization and Management to Drive ‘SMART 2030’ Plan
Feb 24, 2026
DKS Co., Ltd. announced a series of organizational and personnel changes effective April 1, 2026, aimed at accelerating its medium-term management plan “SMART 2030.” The company will optimize divisional structures and enhance cross-fun...
DKS Launches New Shareholder Benefit Program to Strengthen Investor Loyalty
Feb 24, 2026
DKS Co. Ltd. has approved the introduction of a new shareholder benefit program for the next fiscal year, designed to reward investors holding at least 100 shares as of March 31 with tiered benefit points. These points can be redeemed via the DKS ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.